GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vycor Medical Inc (OTCPK:VYCO) » Definitions » Cyclically Adjusted PB Ratio

Vycor Medical (Vycor Medical) Cyclically Adjusted PB Ratio : 8.58 (As of May. 23, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vycor Medical Cyclically Adjusted PB Ratio?

As of today (2024-05-23), Vycor Medical's current share price is $0.08575. Vycor Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.01. Vycor Medical's Cyclically Adjusted PB Ratio for today is 8.58.

The historical rank and industry rank for Vycor Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

VYCO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.94   Med: 8.4   Max: 11.18
Current: 11.18

During the past years, Vycor Medical's highest Cyclically Adjusted PB Ratio was 11.18. The lowest was 5.94. And the median was 8.40.

VYCO's Cyclically Adjusted PB Ratio is ranked worse than
92.13% of 470 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs VYCO: 11.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vycor Medical's adjusted book value per share data for the three months ended in Mar. 2024 was $-0.108. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.01 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vycor Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Vycor Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vycor Medical Cyclically Adjusted PB Ratio Chart

Vycor Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 8.21

Vycor Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 8.21 12.13

Competitive Comparison of Vycor Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Vycor Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vycor Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vycor Medical's Cyclically Adjusted PB Ratio falls into.



Vycor Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Vycor Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.08575/0.01
=8.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vycor Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Vycor Medical's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.108/131.7762*131.7762
=-0.108

Current CPI (Mar. 2024) = 131.7762.

Vycor Medical Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.137 100.560 0.180
201409 0.316 100.428 0.415
201412 0.268 99.070 0.356
201503 0.218 99.621 0.288
201506 0.181 100.684 0.237
201509 0.139 100.392 0.182
201512 0.105 99.792 0.139
201603 0.080 100.470 0.105
201606 0.060 101.688 0.078
201609 0.036 101.861 0.047
201612 -0.002 101.863 -0.003
201703 0.043 102.862 0.055
201706 0.043 103.349 0.055
201709 0.021 104.136 0.027
201712 0.004 104.011 0.005
201803 -0.014 105.290 -0.018
201806 -0.011 106.317 -0.014
201809 -0.019 106.507 -0.024
201812 -0.033 105.998 -0.041
201903 -0.041 107.251 -0.050
201906 -0.042 108.070 -0.051
201909 -0.051 108.329 -0.062
201912 -0.054 108.420 -0.066
202003 -0.060 108.902 -0.073
202006 -0.063 108.767 -0.076
202009 -0.071 109.815 -0.085
202012 -0.072 109.897 -0.086
202103 -0.080 111.754 -0.094
202106 -0.072 114.631 -0.083
202109 -0.073 115.734 -0.083
202112 -0.078 117.630 -0.087
202203 -0.082 121.301 -0.089
202206 -0.081 125.017 -0.085
202209 -0.087 125.227 -0.092
202212 -0.090 125.222 -0.095
202303 -0.095 127.348 -0.098
202306 -0.092 128.729 -0.094
202309 -0.099 129.860 -0.100
202312 -0.102 129.419 -0.104
202403 -0.108 131.776 -0.108

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vycor Medical  (OTCPK:VYCO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Vycor Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Vycor Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vycor Medical (Vycor Medical) Business Description

Traded in Other Exchanges
N/A
Address
951 Broken Sound Boulevard, Suite 320, Boca Raton, FL, USA, 33487
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Executives
David Cantor director, officer: President 1 PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 00000
Adrian Liddell director, officer: Chairman ROSEMOUNT, LYNCOMBE VALE ROAD, BATH HI BA2 4LP
Peter C Zachariou director, 10 percent owner, officer: Chief Executive Officer C/O QUE MANAGEMENT INC, 180 VENICK 13RH FL, NEW YORK NY 10014
Lowell Rush director C/O DIRECT INSITE CORP., 500 EAST BROWARD BOULEVARD, SUITE 1550, FORT LAUDERDALE FL 33394
Oscar Bronsther director 4 AUTUMNWOOD COURT, THE WOODLANDS TX 77380
Steven Girgenti director C/O HEALTHWORLD CORP, 100 AVENUE OF THE AMERICAS, NEW YORK NY 10013
Fountainhead Capital Management Ltd 10 percent owner PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 JE45RP

Vycor Medical (Vycor Medical) Headlines